Innovative Solutions Tailored for Your Needs
Join us at DCAT Week 2025
Chairman and MD
President & Head – LMS
EVP, Preclinical Biology and DMPK
V.P, Global Business Development
More than a decade of unparalleled experience in offering end-to-end Scientific Solutions
Tune in to resources which is a treasure of Blogs, Case Studies and Media publications. Read more as we unfold stories and unique case studies with some of the most influential and ingenious leaders in the bio-pharma community and beyond.
Get Expert view & whats trending from thought leaders in Bio Pharma on Drug Development, Discovery, Manufacturing and Speciality Chemicals.
We have been a part of Global Events like DCAT week and DDC. Our local manufacturing and R&D facilities with a global presence makes us unique. Find out where are we going next.
Vamsi Maddipatla is the Chairman and Managing Director of LAXAI. He is a visionary and an entrepreneur with 17 years of experience in technology and bio-pharma industries. He is also the Founder and ex-CEO of LAXAI Pharma Ltd. – a clinical data services company based in NJ, USA and was associated with Pfizer, Wyeth Pharmaceuticals, Johnson & Johnson and Deloitte.
Vamsi provides a unique blend of operational and financial experience along with a strong and expansive network of key influencers, industry experts and financial partners. He delivers a visionary understanding of Customer challenges and opportunities, and the instinctive ability to facilitate collaboration between the right people to turn strategic concepts into actionable plans and ultimately into business results.
Ganesh Venkatraman brings about 15+ years of Experience in Chemical and Pharmaceutical Industries. He has built, led and managed business teams across geographies covering various portfolios. His focus is to identify critical business drivers across global markets and in accordance with changing market dynamics.
He was previously associated with Piramal Pharma Solutions, Jubilant Biosys Limited and Dr. Reddy’s Laboratories. Ganesh holds a Master degree in Business Administration and Bachelors in Engineering.
Ramesh Mullangi brings about 25+ Years of experience in Drug Metabolism, Pharmacokinetics and Toxicology. He was previously associated with Jubilant Biosys Limited and Dr. Reddy’s Research Foundation in India.
He has a key expertise in leading integrated drug discovery programs across diverse therapeutic areas and filed INDs for over 10 NCEs. He authored over 250+ publications, posters, reviews and patents. He serves as the Editorial Advisory Board member for Bioanalysis and Journal of Pharmaceutical and Biomedical Analysis journals and Reviewer Panel member for Current Pharmaceutical Analysis journal.